CLONICEL (clonidine HCl sustained release)

DRUG2 trials

Sponsors

Addrenex Pharmaceuticals, Inc., Shionogi

Conditions

ADHDAttention Deficit Hyperactivity Disorder

Phase 3

CLONICEL (Clonidine Sustained Release) as Add-on to Stimulant Medication in 6 to 17 Yr-olds With ADHD

CompletedNCT00641329

Addrenex Pharmaceuticals, Inc.ADHD

Start: 2008-02-29End: 2009-02-28Updated: 2010-04-09

Open-Label, Chronic Exposure, Safety Study of CLONICEL (Clonidine HCl Sustained Release) in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

CompletedNCT00723190

ShionogiAttention Deficit Hyperactivity Disorder

Start: 2008-01-31End: 2010-06-30Updated: 2018-04-18